Forest Laboratories Inc (FRX) Financial Statements (2025 and earlier)

Company Profile

Business Address 909 THIRD AVENUE
NEW YORK, NY 10022
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
3/31/2013
Q4
12/31/2012
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,024,1041,677,8111,654,1381,674,8731,719,905
Cash and cash equivalent2,322,433920,454834,990935,675948,903
Short-term investments701,671757,357819,148739,198771,002
Receivables(2,040)(2,027)(2,006)(2,003)(2,020)
Inventory, net of allowances, customer advances and progress billings438,002487,793459,847393,901381,846
Inventory438,002487,793459,847393,901381,846
Prepaid expense186,151   
Other current assets  130,194101,913134,525
Prepaid expense and other current assets109,226
Other undisclosed current assets646,901708,290783,714746,490667,898
Total current assets:4,293,1183,002,0612,997,6062,947,7862,876,855
Noncurrent Assets
Property, plant and equipment395,573384,421378,627376,960376,045
Long-term investments and receivables1,463,8181,423,3941,305,7061,349,4241,251,057
Long-term investments1,463,8181,423,3941,305,7061,349,4241,251,057
Intangible assets, net (including goodwill)2,785,1702,820,1402,819,8892,840,7302,868,769
Goodwill713,091713,091713,091713,091713,091
Intangible assets, net (excluding goodwill)2,072,0792,107,0492,106,7982,127,6392,155,678
Other noncurrent assets121,063106,950106,770114,682
Prepaid expense and other noncurrent assets112,584
Total noncurrent assets:4,765,6244,734,9054,610,9924,681,7964,608,455
TOTAL ASSETS:9,058,7427,736,9667,608,5987,629,5827,485,310
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,040,030993,065999,7951,179,686945,990
Employee-related liabilities   181,995 
Accounts payable77,46766,573142,418157,34977,582
Accrued liabilities962,563926,492857,377840,342868,408
Other undisclosed current liabilities   (181,995) 
Total current liabilities:1,040,030993,065999,795997,691945,990
Noncurrent Liabilities
Liabilities, other than long-term debt825,381827,518822,592850,556846,185
Deferred tax liabilities, net257,031264,413268,858283,245272,251
Liability for uncertainty in income taxes528,447523,740515,651567,311573,934
Other liabilities39,90339,36538,083  
Other undisclosed noncurrent liabilities1,200,000  36,08025,219
Total noncurrent liabilities:2,025,381827,518822,592886,636871,404
Total liabilities:3,065,4111,820,5831,822,3871,884,3271,817,394
Equity
Equity, attributable to parent5,993,3315,916,3835,786,2115,745,2555,667,916
Common stock43,40043,29343,19343,03942,998
Treasury stock, value(5,171,650)(5,165,171)(5,163,951)(5,162,315)(5,162,146)
Additional paid in capital1,951,1241,888,9801,838,5131,799,0711,775,466
Accumulated other comprehensive income (loss)3,887672(10,166)10,1161,697
Retained earnings9,166,5709,148,6099,078,6229,055,3449,009,901
Total equity:5,993,3315,916,3835,786,2115,745,2555,667,916
TOTAL LIABILITIES AND EQUITY:9,058,7427,736,9667,608,5987,629,5827,485,310

Income Statement (P&L) ($ in thousands)

3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
3/31/2013
Q4
12/31/2012
Q3
Revenues878,396855,255832,935821,671722,690
Revenue, net878,396847,454828,771813,826716,281
Cost of revenue
(Cost of Product and Service Sold)
(182,270)(163,718)(165,367)(177,826)(153,311)
Gross profit:696,126691,537667,568643,845569,379
Operating expenses(674,487)(599,922)(661,919)(712,927)(753,670)
Operating income (loss):21,63991,6155,649(69,082)(184,291)
Nonoperating income (expense)6837,8014,1647,8456,409
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (7,801)28,46892,055(6,409)
Income (loss) from continuing operations before income taxes:22,32291,61538,28130,818(184,291)
Income tax expense (benefit)(4,361)(21,628)(15,003)14,62530,683
Income (loss) from continuing operations:17,96169,98723,27845,443(153,608)
Income (loss) before gain (loss) on sale of properties:17,96169,98723,27845,443(153,608)
Net income (loss) available to common stockholders, diluted:17,96169,98723,27845,443(153,608)

Comprehensive Income ($ in thousands)

3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
3/31/2013
Q4
12/31/2012
Q3
Net income (loss):17,96169,98723,27845,443(153,608)
Other comprehensive income (loss)3,21510,838(20,282)  
Other undisclosed comprehensive income    13,050 
Comprehensive income (loss):21,17680,8252,99658,493(153,608)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (4,631)6,978
Comprehensive income (loss), net of tax, attributable to parent:21,17680,8252,99653,862(146,630)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: